Medicine and Dentistry
Ex Vivo
75%
Parkinson's Disease
66%
Amyotrophic Lateral Sclerosis
56%
Regulatory T Cell
55%
Alzheimer's Disease
55%
Serositis
50%
Synuclein
50%
In Vitro
46%
Microglia
45%
Diseases
42%
Myeloid Cell
37%
T Cell Proliferation
31%
Biological Marker
31%
Neurodegeneration
30%
Interleukin 2
26%
Regulatory T Lymphocyte
25%
Metabotropic Receptor 4
25%
Allosteric Modulator
25%
Fractalkine
25%
Combination Therapy
25%
T-Helper Cell
25%
Immunosuppressive Drug
25%
M2 Macrophages
25%
Antigen Presentation
25%
Abatacept
25%
Neuroinflammation
24%
T Cell
15%
Phagocytosis
15%
Dopaminergic Neuron
13%
Intranasal Drug Administration
12%
Light Chain
12%
Oxidative Stress
12%
Interleukin 18
12%
4 Hydroxynonenal
12%
Neurofilament
12%
Oxidized Low Density Lipoprotein
12%
Induced Pluripotent Stem Cell
10%
Disease Exacerbation
10%
Adeno Associated Virus Vector
10%
Serotype
10%
Neuroprotective Agent
10%
Subcutaneous Injection
8%
Inflammatory Cytokine
8%
Chemokine
8%
Knock Out
8%
Cellular Infiltration
8%
Nerve Cell Degeneration
8%
Cytokine Release
8%
Innate Immunity
8%
Adaptive Immunity
8%
Neuroscience
Neurodegeneration
100%
T Cell
85%
Alzheimer's Disease
75%
Parkinson's Disease
71%
Amyotrophic Lateral Sclerosis
62%
In Vivo
50%
Synuclein
50%
In Vitro
45%
Microglia
43%
Major Histocompatibility Complex
42%
Myeloid
37%
Cell Proliferation
31%
Neurodegenerative Disorder
26%
Metabotropic Glutamate Receptor 4
25%
MiR-155
25%
Fractalkine
25%
Dopaminergic
25%
Oxidative Stress
25%
Alpha-Synuclein
25%
Cell Death
25%
Acute Phase Protein
25%
CD4
25%
Cell Infiltration
15%
Oxidized Low Density Lipoprotein
15%
Neuroprotective Agent
13%
Immunotherapy
12%
CX3CR1
12%
Anti-Inflammatory
12%
Acquired Immunity
11%
Dopaminergic Neuron
11%
Substantia Nigra Pars Compacta
11%
Macrophage
10%
Central Nervous System
8%
Lipopolysaccharide Binding Protein
8%
Chemokine
8%
Striatum
7%
Flow Cytometry
7%
Immunocytochemistry
7%
Small Hairpin RNA
7%
Adeno-Associated Virus
7%
Gene Expression
6%
Chemokine Receptor CX3CR1
6%
Neuromuscular Disorder
6%
CD14
5%
Artificial Neural Network
5%
C-Reactive Protein
5%
Keyphrases
Neurodegeneration
58%
Alpha-synuclein (α-syn)
50%
Parkinson's Disease
46%
Disease Progression
35%
MHC Class II
30%
Inflammation
28%
Alzheimer's Disease
28%
Peripheral Monocytes
25%
Dopaminergic Neurodegeneration
25%
Microglial Activation
25%
Metabotropic Glutamate Receptor Subtype 4 (mGlu4)
25%
Neurodegenerative Diseases
25%
Translational Therapeutics
25%
Peripheral Disease
25%
Immune Alterations
25%
Positive Allosteric Modulator
25%
Disease Severity
25%
Amyotrophic Lateral Sclerosis
25%
Anti-neuroinflammation
25%
CD4 T Cells
25%
Peripheral Inflammation
25%
Disease Model
25%
Induced Activation
25%
Human Clinical Samples
25%
T Cell Proliferation
25%
Stress Phase
25%
Immune Regulation
25%
Clinical Model
25%
Acute Phase Proteins
25%
Parkinson's Disease Model
25%
Interleukine-2
25%
CCR2
20%
Extracellular Vehicles
18%
Prodromal Alzheimer's Disease
16%
Central Nervous System
15%
Microglia
12%
Disease Burden
10%
Soluble CD14 (sCD14)
10%
Serotype 2
10%
CX3CR1
10%
Average Rate of Change
10%
IgG Deposition
9%
Neuroprotective Therapy
9%
Inflammatory Chemokines
9%
Inflammatory Cytokines
9%
In Vivo Expression
9%
Viral
9%
Innate Immune Response
9%
Overexpression
9%
Dopaminergic Neurons
9%